Logo

American Heart Association

  98
  0


Final ID: 4145513

Substrate Characterization and Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients with Non-Ischemic Dilated Cardiomyopathy and Isolated Apical Scar

Abstract Body (Do not enter title and authors here): Background: Patients with non-ischemic dilated cardiomyopathy (NIDCM) and ventricular tachycardia (VT) typically have a basal perivalvular substrate with predominant antero-septal or infero-lateral distribution. Isolated apical substrate responsible for VT in NIDCM has not been previously characterized.
Objectives: The purpose of this study is to characterize the prevalence, characteristics and catheter ablation outcomes of NIDCM with isolated apical VT substrate.
Methods: Patients with NIDCM and VT from an isolated apical scar were identified from a prospective registry of consecutive patients with NIDCM undergoing VT ablation between 2018 and 2023. Isolated apical scar was defined as apical abnormal bipolar low voltage area (LVA, <1.5 mV for the endocardium, <1.0 mV for the epicardium with abnormal electrograms) demonstrated to participate in VT with activation, entrainment and/or pace mapping in the absence of abnormal electroanatomic substrate in other LV segments. Patients with hypertrophic cardiomyopathy were excluded.
Results: Out of 208 patients with NIDCM and VT undergoing catheter ablation during the study period, 5 (2.4%; age 52±10 years, LVEF 37±12%) had isolated apical substrate and underwent a total of 8 ablation procedures (2 endocardial, 6 endo-epicardial). One patient had isolated apical scar on pre-procedural cardiac MRI. All patients had both endocardial and epicardial scar identified. At the end of the procedure, non-inducibility of any VTs was achieved in all cases. After a median follow-up of 11 months (range 6-14 months) after the last procedure, there were no deaths and all patients remained free from recurrent VT.
Conclusion: In patients with NIDCM, isolated apical VT substrate is rare. Endo-epicardial catheter ablation is typically needed in these patients and is associated with good VT control over follow-up.
  • Liao, Yi Wen Becky  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Hussein, Ayman  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Kanj, Mohamed  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Kochar, Arshneel  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Koeth, Robert  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Lee, Justin  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Martin, David  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Mayuga, Kenneth  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Nakhla, Shady  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Rickard, John  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Saliba, Walid  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Baranowski, Bryan  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Sroubek, Jakub  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Taigen, Tyler  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Varma, Niraj  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Wazni, Oussama  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Santangeli, Pasquale  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Bhargava, Mandeep  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Callahan, Thomas  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Chung, Mina  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Courson, Jeffery  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Dresing, Thomas  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Higuchi, Koji  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Hight, Nolan  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Author Disclosures:
    Yi Wen Becky Liao: DO NOT have relevant financial relationships | Ayman Hussein: No Answer | Mohamed Kanj: DO NOT have relevant financial relationships | Arshneel Kochar: DO NOT have relevant financial relationships | Robert Koeth: DO NOT have relevant financial relationships | Justin Lee: DO have relevant financial relationships ; Speaker:Boston Scientific:Past (completed) | David Martin: No Answer | Kenneth Mayuga: No Answer | Shady Nakhla: No Answer | John Rickard: No Answer | Walid Saliba: DO have relevant financial relationships ; Advisor:boston scientific:Active (exists now) ; Advisor:siemens:Active (exists now) ; Advisor:biosense webster:Active (exists now) | Bryan Baranowski: DO NOT have relevant financial relationships | Jakub Sroubek: DO NOT have relevant financial relationships | Tyler Taigen: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Biosense Webster:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Niraj Varma: DO have relevant financial relationships ; Researcher:Impulse Dynamics:Active (exists now) | Oussama Wazni: DO have relevant financial relationships ; Consultant:boston scientific:Active (exists now) ; Speaker:Boston Scientific:Past (completed) | Pasquale Santangeli: No Answer | Mandeep Bhargava: DO NOT have relevant financial relationships | Thomas Callahan: DO have relevant financial relationships ; Speaker:Medtronic:Active (exists now) ; Consultant:Merritt:Past (completed) ; Consultant:Shockwave:Past (completed) ; Speaker:Boston Scientific:Active (exists now) ; Speaker:Abbott:Active (exists now) ; Speaker:Philips:Active (exists now) | Mina Chung: DO NOT have relevant financial relationships | Jeffery Courson: DO NOT have relevant financial relationships | Thomas Dresing: DO NOT have relevant financial relationships | Koji Higuchi: DO NOT have relevant financial relationships | Nolan Hight: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Viva Voce! Veritable Voices on VT ablation

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Abstract Oral Session

More abstracts on this topic:
Diffuse Functional and Structural Abnormalities in Fibrosis: Potential Structural Basis for Sustaining Atrial Fibrillation

Kwan Eugene, Dosdall Derek, Ranjan Ravi, Ghafoori Elyar, Good Wilson, Regouski Misha, Moon Boyce, Fish Jeffrey, Hsu Edward, Polejaeva Irina, Macleod Rob

Anatomical Stroke Topography Predicts Ventricular and Atrial Ectopic Burden

Seth Jayant, Rabkin Simon

More abstracts from these authors:
Characteristics and Outcomes of Ventricular Tachycardia Ablation in Patients with the HeartMate 3 Left Ventricular Assist Devices: Results From a Large Single-Center Registry

Zghyer Fawzi, Mayuga Kenneth, Finet J. Emanuel, Martin David, Bhargava Mandeep, Chung Mina, Courson Jeffery, Sroubek Jakub, Nakagawa Hiroshi, Koeth Robert, Higuchi Koji, Tabaja Chadi, Weiss Aaron, Hussein Ayman, Baranowski Bryan, Tang Wai Hong, Dresing Thomas, Callahan Thomas, Taigen Tyler, Kanj Mohamed, Saliba Walid, Soltesz Edward, Liuba Ioan, Wazni Oussama, Starling Randall, Santangeli Pasquale, Liao Yi-wen, Younis Arwa, Kochar Arshneel, Lee Justin, Nakhla Shady, Rickard John

Cardiovascular, Kidney, and Metabolic (CKM) Syndrome is associated with increased risk for arrhythmia recurrence following atrial fibrillation (AF) ablation

Wass Sojin, Lee Justin, Martin David, Saliba Walid, Santangeli Pasquale, Sroubek Jakub, Taigen Tyler, Varma Niraj, Wazni Oussama, Chung Mina, Younis Arwa, Baranowski Bryan, Bhargava Mandeep, Callahan Thomas, Higuchi Koji, Hussein Ayman, Kanj Mohamed, Kochar Arshneel

You have to be authorized to contact abstract author. Please, Login
Not Available